Nature CommunicationsImmunologyPeer-reviewed journal article
Structural Basis for Childhood Antibody Recognition of The Human Metapneumovirus Fusion Protein
Ahmed Magdy KhaliliD, Behrouz Ghazi EsfahaniiD, Rose J. MilleriD, Jiachen Huang, Guillermina M. KuaniD, Ángel BalmasedaiD, Aubree L. GordoniD, Jarrod J. MousaiD
Abstract
Human metapneumovirus (hMPV) is a significant cause of acute respiratory illness in children and adults, with the majority of children being seropositive for hMPV by five years of age. Infants, older adults, and immunocompromised individuals are more susceptible to severe hMPV infections that can lead to hospitalization and death. The hMPV fusion (F) protein is the sole target of neutralizing antibodies, and while the most common neutralizing epitopes on the hMPV F protein targeted by B cells in hMPV-infected adults have been previously determined, the antibody response in hMPV-infected children remains undefined. We isolated a panel of human monoclonal antibodies (mAbs) from children previously infected with hMPV (MPV498, MPV499, MPV510, MPV511, and MPV513), and the mAbs were assessed for binding avidity, neutralization potency, epitope specificity, and in vivo efficacy. All mAbs were neutralizing, and epitope binning revealed the presence of four different epitopes targeted by the mAbs. We determined the cryo-EM structures of four mAbs in complex with the hMPV F protein, which revealed epitopes located on the hMPV F trimer surface as well as an intratrimer epitope located completely within the hMPV F trimer interface. Furthermore, we determined the prophylactic efficacy of the mAbs in protection against hMPV challenge in mice. Overall, our data reveal new insights into the immunodominant antigenic epitopes on the hMPV F protein in children and identify new mAb therapies for hMPV F disease prevention.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 2
- FWCI
- 1.39
- Field percentile
- top 16%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural basis for ultrapotent neutralization of human metapneumovirus
A. Banerjee, J. Huang, … J. J. Mousa·bioRxiv·Mar 14, 2022
- Antibody recognition of the Pneumovirus fusion protein trimer interface
J. Huang, D. Diaz, J. J. Mousa·bioRxiv·May 20, 2020
- Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus
S. A. Rush, G. Brar, … J. S. McLellan·bioRxiv·Mar 28, 2022
- Structure, immunogenicity, and conformation-dependent receptor binding of the post-fusion human metapneumovirus F protein
J. Huang, P. Chopra, … J. J. Mousa·bioRxiv·May 19, 2021
- DEVELOPMENT OF A POTENT MONOCLONAL ANTIBODY FOR TREATMENT OF HUMAN METAPNEUMOVIRUS INFECTIONS
Evelyn D. Harris, Morgan McGovern, … Jim B. Boonyaratanakornkit·Nature CommunicationsPeer-reviewed·Feb 12, 2026
- A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein
J. Huang, R. Miller, J. J. Mousa·bioRxiv·Feb 24, 2022